Loading clinical trials...
Loading clinical trials...
Browse 986 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.
Find trials near:
Showing 821-840 of 986 trials
NCT00345709
Long-Term Objectives: * To establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTMDACC's Department of Gynecologic Oncology for research purposes. * To create a bank of low grade and LMP ovarian cancer tumor blocks for study of the molecular and histopathologic differences among low grade ovarian cancer, ovarian LMP tumors and high grade ovarian cancer. * To specify the epidemiologic and clinical profile of low grade and LMP ovarian cancer patients. * To identify potential precursors of low grade and LMP ovarian cancer. * To assess treatment patterns to guide management of these diseases. * To collect quality of life and health outcomes data on these patients. * To achieve a fundamental understanding of low grade and LMP ovarian cancer that will inform prevention and screening efforts, motivate development of improved treatments and eventually result in a cure. The short-term objectives are: * To detail procedures for potential registrant identification and recruitment. * To create a demographic and health history questionnaire for potential registrants. * To begin aggregating low grade and low malignant potential ovarian tumor blocks. * To specify a timeline for the development of all other aspects of the Registry.
NCT00532194
The purpose of this study is to assess the safety and efficacy of cediranib in combination with standard chemotherapy, in patients who have relapsed with ovarian, fallopian tube or epithelial cancer, after first line platinum based treatment.
NCT01296035
This is a study to find out if the study drug, panitumumab, when given with gemcitabine works in treating ovarian cancer and to find out what side effects occur when they are given together.